R&D
研究开发
Product Pipeline
- Categories:R&D
- Time of issue:2020-03-12 00:00:00
- Views:0
Description:
Information
After years of research and development, we have a balanced and diversified product pipeline with a strategic focus on major cancers and other AR related diseases.
Note: 1.In addition, IND for basal-cell carcinoma indication has been cleared by FDA in the U.S.; 2. Will conduct phase II clinical trial directly due to good safety, and the protocol is under preparation
Scan the QR code to read on your phone
Business
News Center
Contact Us
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights. 苏ICP备19028699号-2 Powered by 300.cn
Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn